Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.
作者信息
Ambesh Paurush, Zivari Kaveh, Obiagwu Chukwudi, Shetty Vijay, Kamholz Stephan, Hollander Gerald, Shani Jacob
机构信息
Department of Internal Medicine, Maimonides Medical Center, New York City, USA.
Department of Cardiology, Maimonides Medical Center, New York City, USA.
出版信息
Br J Clin Pharmacol. 2018 Apr;84(4):800-802. doi: 10.1111/bcp.13509. Epub 2018 Feb 9.
Abstract
摘要
相似文献
1
Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.卡培他滨心脏毒性导致的快速进展性心力衰竭：一例病例报告
Br J Clin Pharmacol. 2018 Apr;84(4):800-802. doi: 10.1111/bcp.13509. Epub 2018 Feb 9.
2
Cardiotoxicity of capecitabine: Captions not to bin.卡培他滨的心脏毒性：标题请勿丢弃。
Int J Cardiol. 2017 Feb 15;229:6. doi: 10.1016/j.ijcard.2016.11.314. Epub 2016 Dec 6.
3
Capecitabine cardiotoxicity: How to limit life-threatening events.卡培他滨的心脏毒性：如何限制危及生命的事件。
Int J Cardiol. 2017 Feb 15;229:5. doi: 10.1016/j.ijcard.2016.11.310. Epub 2016 Dec 6.
4
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.卡培他滨相关心脏毒性在转移性结直肠癌不同治疗方案中的发生率：荷兰结直肠癌研究组CAIRO研究的回顾性分析
Eur J Cancer. 2017 May;76:93-99. doi: 10.1016/j.ejca.2017.02.009. Epub 2017 Mar 10.
5
Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.卡培他滨所致症状性心脏毒性的发生率及危险因素：对452例连续性转移性乳腺癌患者的回顾性研究
BMJ Open. 2016 Oct 19;6(10):e012798. doi: 10.1136/bmjopen-2016-012798.
6
Rechallenging 5-Fluorouracil in a Patient With Capecitabine-Induced Ventricular Fibrillation.对一名发生卡培他滨诱导的心室颤动患者再次使用5-氟尿嘧啶。
Clin Colorectal Cancer. 2015 Sep;14(3):198-201. doi: 10.1016/j.clcc.2015.02.005. Epub 2015 Mar 6.
7
Capecitabine-induced hyperglycemia without hyperlipidemia: a case report.卡培他滨诱发的无高脂血症的高血糖症：一例报告
Eur J Clin Pharmacol. 2017 Nov;73(11):1519-1521. doi: 10.1007/s00228-017-2304-5. Epub 2017 Jul 27.
8
Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.使用次优剂量治疗对5-氟尿嘧啶和卡培他滨有心脏毒性反应的晚期结直肠癌患者。
BMJ Case Rep. 2017 Nov 27;2017:bcr-2017-220952. doi: 10.1136/bcr-2017-220952.
9
Capecitabine-induced myopericarditis - A case report and review of literature.
J Oncol Pharm Pract. 2019 Jun;25(4):1006-1010. doi: 10.1177/1078155218774871. Epub 2018 May 21.
10
Cardiac arrest and ventricular fibrillation in a young man treated with capecitabine: Case report and literature review.一名接受卡培他滨治疗的年轻男性发生心脏骤停和心室颤动：病例报告及文献综述
Int J Cardiol. 2016 Oct 1;220:280-3. doi: 10.1016/j.ijcard.2016.06.117. Epub 2016 Jun 23.
引用本文的文献
1
Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.接受嘧啶类似物阿扎胞苷治疗的患者发生心力衰竭：病例报告及Vigibase中的不成比例性分析
Br J Clin Pharmacol. 2020 May;86(5):991-998. doi: 10.1111/bcp.14211. Epub 2020 Feb 3.
本文引用的文献
1
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.2018 年 IUPHAR/BPS 药理学指南：更新和扩展，以包含新的免疫药理学指南。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.
2
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.《药理学简明指南 2017/18：酶》
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S272-S359. doi: 10.1111/bph.13877.
3
Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?卡培他滨致心脏毒性：更多的证据还是临床方法来保护患者的心脏？
Onco Targets Ther. 2014 Sep 29;7:1783-91. doi: 10.2147/OTT.S65653. eCollection 2014.
4
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives.5-氟尿嘧啶体外心脏毒性的机制研究及临床和职业视角。
Toxicol Lett. 2014 Jun 16;227(3):151-6. doi: 10.1016/j.toxlet.2014.03.018. Epub 2014 Apr 1.
5
5-fu metabolism in cancer and orally-administrable 5-fu drugs.癌症中的 5-氟尿嘧啶代谢和可口服的 5-氟尿嘧啶药物。
Cancers (Basel). 2010 Sep 17;2(3):1717-30. doi: 10.3390/cancers2031717.
6
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors.接受氟尿嘧啶或卡培他滨治疗的癌症患者的心脏毒性：发生率、表现和易患因素的系统评价。
Cancer Treat Rev. 2013 Dec;39(8):974-84. doi: 10.1016/j.ctrv.2013.03.005. Epub 2013 Apr 10.
7
Capecitabine may induce coronary artery vasospasm.卡培他滨可能会诱发冠状动脉痉挛。
Hellenic J Cardiol. 2012 Jul-Aug;53(4):320-3.
8
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.抗癌药物的心脏毒性：需要肿瘤心脏病学和肿瘤心脏病学预防。
J Natl Cancer Inst. 2010 Jan 6;102(1):14-25. doi: 10.1093/jnci/djp440. Epub 2009 Dec 10.
9
5-Fluorouracil induces arterial vasocontractions.5-氟尿嘧啶可诱导动脉血管收缩。
Ann Oncol. 2004 Apr;15(4):661-4. doi: 10.1093/annonc/mdh150.
10
5-fluorouracil-induced coronary vasospasm.5-氟尿嘧啶诱导的冠状动脉痉挛。
Cancer Control. 2004 Jan-Feb;11(1):46-9. doi: 10.1177/107327480401100207.
Zotero 插件